(Q54382105)

29 May 2018

title

Hyperglucagonism and glucagon resistance in cirrhosis. Paradoxical effect of propranolol on plasma glucagon levels. (English)

1 reference

29 May 2018

1 reference

G Silva

1

1 reference

29 May 2018

R Gomis

2

1 reference

29 May 2018

J Bosch

3

1 reference

29 May 2018

R Casamitjana

4

1 reference

29 May 2018

R Mastai

5

1 reference

29 May 2018

M Navasa

6

1 reference

29 May 2018

F Rivera

7

1 reference

29 May 2018

J Rodés

8

1 reference

29 May 2018

publication date

1 June 1988

1 reference

29 May 2018

published in

Journal of Hepatology

1 reference

29 May 2018

volume

6

1 reference

29 May 2018

issue

3

1 reference

29 May 2018

page(s)

325-331

1 reference

29 May 2018

Elevated plasma glucagon levels in cirrhosis of the liver.

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2888%2980049-7

7 January 2021

Hyperglucagonemia in Laennec's cirrhosis. The role of portal-systemic shunting

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2888%2980049-7

7 January 2021

Hyperglucagonaemia in cirrhosis. Relationship to hepatocellular damage.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2888%2980049-7

7 January 2021

Effect of portasystemic venous shunt surgery on hyperglucagonaemia in cirrhosis: paired studies of pre- and post-shunted subjects

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2888%2980049-7

7 January 2021

Insulin and glucagon concentrations in portal and peripheral veins in patients with hepatic cirrhosis

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2888%2980049-7

7 January 2021

Stimulation of glucagon and insulin secretion by acetylcholine infused intrapancreatically.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2888%2980049-7

7 January 2021

Mechanisms involved in the exercise-induced increase in glucagon secretion in rats.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2888%2980049-7

7 January 2021

Adrenergic receptors and the secretion of glucagon and insulin from the isolated, perfused canine pancreas

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2888%2980049-7

7 January 2021

Sympathetic nervous activity and renal and systemic hemodynamics in cirrhosis: plasma norepinephrine concentration, hepatic extraction, and renal release

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2888%2980049-7

7 January 2021

Sympathetic nervous activity, renin-angiotensin system and renal excretion of prostaglandin E2in cirrhosis. Relationship to functional renal failure and sodium and water excretion

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2888%2980049-7

7 January 2021

Sympathetic nervous activity in cirrhosis. A survey of plasma catecholamine studies

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2888%2980049-7

7 January 2021

The metabolic consequences of adrenergic blockade: A review

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2888%2980049-7

7 January 2021

Influence of Beta-Blocking Drugs on Glucose Metabolism in Hypertensive, Non-Diabetic Patients

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2888%2980049-7

7 January 2021

The effect of propranolol on portal hypertension in patients with cirrhosis: a hemodynamic study.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2888%2980049-7

7 January 2021

Propranolol in prevention of recurrent gastrointestinal bleeding in cirrhotic patients

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2888%2980049-7

7 January 2021

Effects of Propranolol on Azygos Venous Blood Flow and Hepatic and Systemic Hemodynamics in Cirrhosis

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2888%2980049-7

7 January 2021

Radioimmunoassay of human proinsulin C-peptide using synthetic human connecting peptide

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2888%2980049-7

7 January 2021

A Sensitive Double Antibody Immunoassay for Human Growth Hormone in Plasma

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2888%2980049-7

7 January 2021

Simultaneous single isotope radioenzymatic assay of plasma norepinephrine, epinephrine and dopamine

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2888%2980049-7

7 January 2021

THE COLORIMETRIC MICRO-DETERMINATION OF NON-ESTERIFIED FATTY ACIDS IN PLASMA

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2888%2980049-7

7 January 2021

Transhepatic glucagon gradients in man: evidence for glucagon extraction by human liver

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2888%2980049-7

7 January 2021

Glucose tolerance and diabetes in chronic liver disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2888%2980049-7

7 January 2021

Glucagon receptor of human liver. Studies of its molecular weight and binding properties, and its ability to activate hepatic adenylyl cyclase of non-obese and obese subjects

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2888%2980049-7

7 January 2021

10.1016/S0168-8278(88)80049-7

Identifiers

DOI

1 reference

29 May 2018

1 reference

29 May 2018